Pharmacological Prophylaxis of Post- Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis
Status:
Unknown status
Trial end date:
2018-12-15
Target enrollment:
Participant gender:
Summary
The investigators aimed to perform a comparative study, evaluating the efficacy of three
prophylactic approaches aiming to reduce the risk of post-ERCP pancreatitis, using
pharmacologic agents with different mechanisms of action (NSAIDs and/or acetylcysteine) in
three different regimens.
Phase:
Phase 4
Details
Lead Sponsor:
Grigore T. Popa University of Medicine and Pharmacy